Evoq Remedies quarterly results and financials

Evoq Remedies (BSE 543500)₹1.60+3.90%(9 Nov 2026 close)Trading & Distributors

Key facts

In the Mar 2026 quarter (standalone), Evoq Remedies reported sales of ₹0 Cr, down 100.0% from Mar 2025, and net profit of −₹0.28 Cr, down 116.5% year on year. For the year to Mar 2026, sales were ₹25.54 Cr and net profit −₹0.23 Cr.

Sales (Mar 2026): ₹0 Cr
Net profit (Mar 2026): −₹0.28 Cr
Sales (FY Mar 2026): ₹25.54 Cr
Net profit (FY Mar 2026): −₹0.23 Cr
EPS (Mar 2026): ₹−0.13
Borrowings (Mar 2026): ₹0.08 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Evoq Remedies quarterly results

₹ crore unless stated; each column is a quarter.

Evoq Remedies Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	4.61	3.91	0.16	0.00	11.77	25.53	0.00
Expenses	8.66	3.84	1.88	1.64	12.39	26.53	0.51
Operating Profit	−4.03	0.06	−1.71	−1.62	−0.59	−0.94	−0.49
OPM %	−87.8%	1.8%	−1,146.7%	—	−5.1%	−3.7%	—
Other Income	6.03	0.00	2.27	0.02	2.41	1.07	0.20
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.05	0.02	0.03
Profit before tax	1.99	0.08	0.53	−1.63	1.77	0.09	−0.34
Tax %	33.9%	28.6%	29.7%	0.0%	2.3%	25.1%	−12.0%
Net Profit	1.30	0.04	0.37	−1.61	1.70	0.04	−0.28
EPS (Rs)	0.97	0.05	0.29	−0.66	0.70	0.03	−0.13

Evoq Remedies profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Evoq Remedies Profit and loss
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	3.26	9.08	10.03	16.79	20.41	4.06	11.77	25.54
Expenses	3.24	9.09	9.09	15.35	24.17	5.70	14.02	27.01
Operating Profit	0.01	0.00	0.94	1.45	−3.72	−1.63	−2.22	−1.44
OPM %	0.6%	0.0%	9.5%	8.7%	−18.3%	−40.5%	−19.0%	−5.7%
Other Income	0.00	0.00	0.00	0.00	6.03	2.27	2.42	1.26
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.02	0.06	0.06
Profit before tax	0.01	0.00	0.96	1.47	2.30	0.60	0.14	−0.26
Tax %	0.0%	—	25.3%	25.4%	29.3%	26.3%	30.8%	−4.0%
Net Profit	0.00	0.00	0.71	1.08	1.61	0.44	0.08	−0.23
EPS (Rs)	10.02	0.00	721.69	0.81	1.20	0.34	0.05	−0.11
Dividend payout %	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Evoq Remedies balance sheet

₹ crore, at each year end.

Evoq Remedies Balance sheet
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.00	0.00	0.00	13.55	13.56	13.56	24.83	24.82
Reserves	0.02	0.02	0.74	9.55	11.18	11.65	19.63	19.39
Borrowings	0.00	0.02	0.00	8.14	9.58	4.25	0.00	0.08
Other Liabilities	2.11	5.59	7.28	1.99	0.53	7.35	5.45	7.53
Total Liabilities	2.13	5.63	8.02	33.23	34.85	36.81	49.91	51.82
Fixed Assets	0.00	0.00	0.00	0.00	0.02	0.02	0.23	0.18
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	2.13	5.63	8.02	33.23	34.83	36.79	49.68	51.64
Inventories	0.02	0.05	0.14	0.77	2.02	3.12	2.21	1.66
Trade receivables	1.24	4.73	6.85	25.46	17.26	1.75	8.64	3.86
Cash & equivalents	0.03	0.00	0.04	3.10	0.16	0.13	0.22	0.02
Total Assets	2.13	5.63	8.02	33.23	34.85	36.81	49.91	51.82

Evoq Remedies cash flow

₹ crore, for each year.

Evoq Remedies Cash flow
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.00	−0.01	0.02	−26.37	−4.34	5.30	−14.58	−0.27
Cash from investing activity	0.00	0.00	0.00	0.00	0.00	0.00	−0.25	0.00
Cash from financing activity	0.00	0.00	0.00	29.50	1.43	−5.33	14.99	0.08
Net cash flow	0.02	−0.03	0.04	3.07	−2.95	−0.04	0.10	−0.22
Capex	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.00
Free cash flow	0.00	−0.01	0.02	−26.40	−4.35	5.30	−14.87	−0.27
CFO / OP %	50.0%	—	3.0%	−1,785.0%	99.0%	−334.0%	654.0%	19.0%

Evoq Remedies ratios

Working-capital days and returns, by year.

Evoq Remedies Ratios
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	138	190	249	552	308	157	268	55
Inventory days	3	2	7	21	38	732	62	24
Days payable	241	228	316	33	−9	768	99	12
Cash conversion cycle	−97	−33	−58	542	358	123	233	69
Working capital days	1	1	26	437	441	2,263	1,369	631
ROCE %	—	0.0%	246.7%	9.1%	6.9%	1.9%	0.4%	−0.6%

Evoq Remedies: frequently asked questions

What are the latest quarterly results of Evoq Remedies?

For the Mar 2026 quarter, Evoq Remedies reported sales of ₹0 Cr, down 100.0% year on year and net profit of −₹0.28 Cr, down 116.5% year on year.

What is the annual revenue of Evoq Remedies?

Evoq Remedies' sales for the year to Mar 2026 were ₹25.54 Cr.

What is the net profit of Evoq Remedies?

Net profit for the year to Mar 2026 was −₹0.23 Cr. Earnings per share over the same trailing period were ₹−0.11.

How much debt does Evoq Remedies have?

Evoq Remedies reported borrowings of ₹0.08 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.

What is the free cash flow of Evoq Remedies?

Cash from operations was −₹0.27 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.27 Cr.

Loading…